# Endovascular GSN Ablation in Subjects With HFpEF

> **NCT04287946** · NA · UNKNOWN · sponsor: **Axon Therapies, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DEVICE:** Ablation

## Key facts

- **NCT ID:** NCT04287946
- **Lead sponsor:** Axon Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2024-06
- **Final completion:** 2024-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04287946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04287946, "Endovascular GSN Ablation in Subjects With HFpEF". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04287946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*